Apoptotic Janus-faced mycotoxins against thoracal and breast metastases
1Department of Molecular Biotechnology and Microbiology and Department of Physiology, University of Debrecen, 1 Egyetem Square, Life Sciences Building 1.102, Debrecen, 4010, Hungary. banfalvi.gaspar@science.unideb.hu.
Abstract:
Abdominal organs (liver, kidney, spleen) are frequent targets of cancer cell invasion but their primary tumours are less known for their metastatic potential to other organs e.g. to the breast. Despite the known connection of the pathogenesis from breast cancer to liver metastasis, the study of the spread in the opposite direction has been neglected. The notion that breast cancer could be a metastasis besides being a primary tumour is based on rodents' tumour models upon implantation of tumour cells under the capsule of the kidney or under the Glisson's capsule of the liver of rats and mice. Tumour cells develop into a primary tumour at the site of subcutaneous implantation. The metastatic process starts with peripheral disruptions of blood vessels near the surface of primary tumours. Tumour cells released into the abdomen cross the apertures of the diaphragm, enter the thoracal lymph nodes and accumulate in parathymic lymph nodes. Abdominal colloidal carbon particles injected into the abdomen faithfully mimicked the migration of tumour cells and deposited in parathymic lymph nodes (PTNs). An explanation is provided why the connection between abdominal tumours and mammary tumours escaped attention, notably, parathymic lymph nodes in humans were referred to as internal mammary or parasternal lymph nodes. The apoptotic effect of Janus-faced cytotoxins is suggested to provide a new approach against the spread of abdominal primary tumours, and metastatic development.
Insights
This study reveals abdominal tumors can metastasize to the breast, challenging the traditional view. Researchers used rodent models to track tumor cell spread to parathymic lymph nodes, suggesting new therapeutic targets.
Area of Science:
- Oncology
- Cancer Metastasis Research
Background:
- Abdominal organs (liver, kidney, spleen) are common sites for cancer invasion, but their primary tumors rarely metastasize to distant sites like the breast.
- The metastatic pathway from breast cancer to the liver is well-documented, yet the reverse pathway, from abdominal tumors to the breast, remains understudied.
Purpose of the Study:
- To investigate the metastatic potential of primary abdominal tumors to the breast.
- To elucidate the migratory pathway of abdominal tumor cells to distant sites, specifically focusing on lymph node involvement.
Main Methods:
- Utilized rodent tumor models by implanting tumor cells under the kidney or liver capsule.
- Tracked tumor cell migration using injected colloidal carbon particles to mimic tumor cell dissemination.
- Examined the role of parathymic lymph nodes (PTNs) in the metastatic process.
Main Results:
- Tumor cells implanted in abdominal organs successfully formed primary tumors.
- Tumor cells disseminated via abdominal cavity, diaphragm apertures, and thoracic lymphatics, accumulating in parathymic lymph nodes (PTNs).
- Colloidal carbon particles demonstrated a similar migration pattern to PTNs, validating the observed tumor cell pathway.
Conclusions:
- Abdominal primary tumors possess the capability to metastasize to the breast, contrary to previous assumptions.
- Parathymic lymph nodes (termed internal mammary or parasternal nodes in humans) are critical in the metastatic spread from abdominal tumors.
- Janus-faced cytotoxins inducing apoptosis present a potential therapeutic strategy against abdominal tumor metastasis.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...


